-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Moderna, Lowers Price Target to $40

Benzinga·05/02/2025 21:24:19
Listen to the news
Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $45 to $40.